Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Designer drugs: mechanism of action and adverse effects
Psychoactive substances with chemical structures or pharmacological profiles that are
similar to traditional drugs of abuse continue to emerge on the recreational drug market …
similar to traditional drugs of abuse continue to emerge on the recreational drug market …
[HTML][HTML] Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics
New psychoactive stimulants and psychedelics continue to play an important role on the
illicit new psychoactive substance (NPS) market. Designer stimulants and psychedelics both …
illicit new psychoactive substance (NPS) market. Designer stimulants and psychedelics both …
Serotonin-releasing agents with reduced off-target effects
Increasing extracellular levels of serotonin (5-HT) in the brain ameliorates symptoms of
depression and anxiety-related disorders, eg, social phobias and post-traumatic stress …
depression and anxiety-related disorders, eg, social phobias and post-traumatic stress …
Vesicular monoamine transporter (VMAT) regional expression and roles in pathological conditions
M Alwindi, A Bizanti - Heliyon, 2023 - cell.com
Vesicular monoamine transporters (VMATs) are key regulators of neurotransmitter release
responsible for controlling numerous physiological, cognitive, emotional, and behavioral …
responsible for controlling numerous physiological, cognitive, emotional, and behavioral …
[HTML][HTML] α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: a pharmacological characterization of interactions between …
While classical cathinones, such as methcathinone, have been shown to be monoamine
releasing agents at human monoamine transporters, the subgroup of α-pyrrolidinophenones …
releasing agents at human monoamine transporters, the subgroup of α-pyrrolidinophenones …
Jump-starting the conversation about harm reduction: making sense of drug effects
This paper describes the history of the development of taxonomies of psychoactive drug use,
and discusses the conceptualization of three recent taxonomies: comparing their features …
and discusses the conceptualization of three recent taxonomies: comparing their features …
Bioisosteric analogs of MDMA: Improving the pharmacological profile?
Methylenedioxymethamphetamine (MDMA,'ecstasy') is re‐emerging in clinical settings as a
candidate for the treatment of specific neuropsychiatric disorders (eg post‐traumatic stress …
candidate for the treatment of specific neuropsychiatric disorders (eg post‐traumatic stress …
Interaction profiles of central nervous system active drugs at human organic cation transporters 1–3 and human plasma membrane monoamine transporter
Many psychoactive compounds have been shown to primarily interact with high-affinity and
low-capacity solute carrier 6 (SLC6) monoamine transporters for norepinephrine (NET; …
low-capacity solute carrier 6 (SLC6) monoamine transporters for norepinephrine (NET; …
Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro
Mephedrone is a largely abused psychostimulant. It elicits the release of monoamines via
the high affinity transporters for dopamine (DAT), norepinephrine (NET) and serotonin …
the high affinity transporters for dopamine (DAT), norepinephrine (NET) and serotonin …
DARK classics in chemical neuroscience: aminorex analogues
Aminorex (5-phenyl-4, 5-dihydro-1, 3-oxazol-2-amine) and 4-methylaminorex (4-methyl-5-
phenyl-4, 5-dihydro-1, 3-oxazol-2-amine) are psychostimulants that have long been listed in …
phenyl-4, 5-dihydro-1, 3-oxazol-2-amine) are psychostimulants that have long been listed in …